These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. The schizophrenia prodrome. White T; Anjum A; Schulz SC Am J Psychiatry; 2006 Mar; 163(3):376-80. PubMed ID: 16513855 [No Abstract] [Full Text] [Related]
64. Do neuroleptics cause depression? Roy A Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454 [TBL] [Abstract][Full Text] [Related]
65. Low dose medication strategies in the maintenance treatment of schizophrenia. Kane JM Schizophr Bull; 1983; 9(4):528-32. PubMed ID: 6140751 [TBL] [Abstract][Full Text] [Related]
66. Relationship between residual symptomatology and auditory evoked potentials in schizophrenic outpatients. Hegerl U; Gaebel W; Ulrich G Pharmacopsychiatry; 1988 Nov; 21(6):329-30. PubMed ID: 2907638 [No Abstract] [Full Text] [Related]
67. Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients. Grodzicki J; Pardo M; Schved G; Schlosberg A; Fuchs S; Kanety H Biol Psychiatry; 1990 Jun; 27(12):1327-30. PubMed ID: 1973057 [No Abstract] [Full Text] [Related]
68. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol]. Dittert S; Soyka M; Winter C; Möller HJ Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340 [No Abstract] [Full Text] [Related]
69. New antipsychotic medications: do research results relate to clinical practice? MacEwan GW Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572 [TBL] [Abstract][Full Text] [Related]
70. Positive and negative symptoms in schizophrenia: where are the data? de Leon J; Simpson GM; Peralta V Biol Psychiatry; 1992 Mar; 31(5):431-4. PubMed ID: 1349829 [No Abstract] [Full Text] [Related]
71. Preliminary trial of clonidine treatment in two patients suffering from chronic schizophrenia. Elizur A; Levy A; Lahav M; Blum I Commun Psychopharmacol; 1980; 4(6):507-17. PubMed ID: 6117398 [No Abstract] [Full Text] [Related]
72. Important issues in the drug treatment of schizophrenia. Davis JM; Schaffer CB; Killian GA; Kinard C; Chan C Schizophr Bull; 1980; 6(1):70-87. PubMed ID: 6102795 [TBL] [Abstract][Full Text] [Related]
73. Depressive symptoms and schizophrenia a psychopharmacological approach. Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G Encephale; 1995; 21(5):555-8. PubMed ID: 8529564 [TBL] [Abstract][Full Text] [Related]
74. Change in quantified electroencephalography (QEEG) with medication and altered clinical state in the same subjects with schizophrenia. Harris A; Gordon E; Anderson J; Ritchie G; McLachlan C; Meares R Schizophr Res; 1997 Jan; 23(1):87-9. PubMed ID: 9050132 [No Abstract] [Full Text] [Related]
75. All antipsychotics are equal, but some are more equal than others. Volavka J; Citrome L J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959 [No Abstract] [Full Text] [Related]
76. The board-and-care home: does it deserve a bad press? van Putten T; Spar JE Hosp Community Psychiatry; 1979 Jul; 30(7):461-4. PubMed ID: 36335 [TBL] [Abstract][Full Text] [Related]
77. [Resistant schizophrenia: what chemotherapy?]. Vanelle JM Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434 [No Abstract] [Full Text] [Related]
78. The effects of a single dose of oxytocin on working memory in schizophrenia. Michalopoulou PG; Averbeck BB; Kalpakidou AK; Evans S; Bobin T; Kapur S; Shergill SS Schizophr Res; 2015 Mar; 162(1-3):62-3. PubMed ID: 25579054 [No Abstract] [Full Text] [Related]
79. A schizophrenic with non-24-hour sleep-wake syndrome. Tagaya H; Matsuno Y; Atsumi Y Jpn J Psychiatry Neurol; 1993 Jun; 47(2):441-2. PubMed ID: 7903725 [No Abstract] [Full Text] [Related]
80. Changes in the hostility of schizophrenic patients during treatment. Tsiantis J; Blackburn IM; Lyketsos GC Br J Med Psychol; 1981 Sep; 54(Pt 3):251-8. PubMed ID: 6115668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]